MANGALAM Intraday Analysis...

MANGALAM Share Price

Open 162.90 Change Price %
High 162.90 1 Day -0.45 -0.28
Low 157.00 1 Week 14.30 9.93
Close 158.25 1 Month 26.45 20.07
Volume 52744 1 Year -82.80 -34.35
52 Week High 295.00
52 Week Low 122.60
MANGALAM Important Levels
Resistance 2 163.72
Resistance 1 161.47
Pivot 159.38
Support 1 155.03
Support 2 152.78
NSE INDIA Most Active Stocks
SUZLON 17.50 0.86%
ICICIBANK 257.55 -2.24%
ADANIPOWER 34.75 1.16%
VISESHINFO 0.20 -20.00%
GMRINFRA 12.55 -1.18%
HINDALCO 181.70 5.85%
JPASSOCIAT 10.00 1.52%
AXISBANK 445.00 -1.28%
IDEA 73.35 2.59%
IBREALEST 80.60 -0.86%
More..
NSE INDIA Top Gainers Stocks
BHARATRAS 2279.55 20.00%
PRAKASHSTL 1.80 20.00%
ORIENTHOT 26.75 19.96%
BHAGYNAGAR 25.25 19.95%
OISL 6.05 19.80%
HOVS 161.40 16.03%
KTIL 234.55 12.93%
NAKODA 0.45 12.50%
DLINKINDIA 125.45 11.76%
BLUECHIP 0.50 11.11%
More..
NSE INDIA Top Losers Stocks
KSERASERA 0.15 -25.00%
VISESHINFO 0.20 -20.00%
SRGINFOTEC 0.35 -12.50%
HOTELRUGBY 4.10 -11.83%
ESL 5.40 -9.24%
ESL 5.40 -9.24%
ESL 5.40 -9.24%
ESL 5.40 -9.24%
SAMTEL 0.50 -9.09%
TECHIN 3.90 -8.24%
More..

Mangalam Drugs And Organics Limited (NSE: MANGALAM)

MANGALAM Technical Analysis 2.5
As on 23rd Jan 2017 MANGALAM Share Price closed @ 158.25 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 175.91 & Strong Buy for SHORT-TERM with Stoploss of 141.98 we also expect STOCK to react on Following IMPORTANT LEVELS.
MANGALAM Target for January
1st Target up-side 147.27
2nd Target up-side 157.2
3rd Target up-side 167.13
1st Target down-side 118.93
2nd Target down-side 109
3rd Target down-side 99.07
MANGALAM Synopsis Technicals View
50 Day EMA N/A (Short Term)
N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
MANGALAM Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
MANGALAM Address
MANGALAM
N/A
MANGALAM Latest News
Mangalam Drugs And Organics Limited   Moneycontrol.com   - 19th Mar 15
Clarification sought from Mangalam Drugs & Organics Ltd   Hindu Business Line   - 19th Mar 15
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011   Hindu Business Line   - 17th Feb 15
Mangalam Drugs' director Rajendra Prasad Mimani resigns   Moneycontrol.com   - 03rd Feb 15
They lied to me for 15 years of my life, says asbestosis-afflicted labourer   Mid-Day   - 21st Jul 14
Fire stops work at Mangalam Organics plant in Maharastra   Business Standard   - 07th Feb 14
CRISIL ratings for Indian debt instruments-Feb 4   Reuters   - 04th Feb 14
Dujodwala Products changes its name to Mangalam Organics   Moneycontrol.com   - 05th Nov 13
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011   Hindu Business Line   - 09th Apr 12
Indian takeovers abroad   The Economist   - 01st Mar 12
Interactive Technical Analysis Chart Mangalam Drugs And Organics Limited ( MANGALAM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Mangalam Drugs And Organics Limited
MANGALAM Business Profile
Mangalam Drugs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 5.57 crore.The company has reported a standalone sales of Rs 28.21 crore and a Net Loss of Rs 0.97 crore for the quarter ended Sep 2013.The company management includes Govardhan M Dhoot - Chairman, Subhash C Khattar - Ind. Non-Executive Director, Rajendraprasad Mimani - Ind. Non-Executive Director. It is listed on the BSE with a BSE Code of 532637 and the NSE with an NSE Code of MANGALAM.Its Registered office is at No 292, Princess Street, 2nd Floor, Near Flyover,,Marine Lines Mumbai,Maharashtra - 400002.Their Registrars are Link Intime India Pvt. Ltd.